WHO ICTRP trial
A randomised, double-blind, placebo-controlled, multi-arm study on the impact of…
DRKS00010230 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00010230 |
|---|---|
| Public title | A randomised, double-blind, placebo-controlled, multi-arm study on the impact of Valproic acid and Pregabalin on approach/avoidance behaviour in healthy individuals |
| Scientific title | A randomised, double-blind, placebo-controlled, multi-arm study on the impact of Valproic acid and Pregabalin on approach/avoidance behaviour in healthy individuals - AAAX2 |
| Primary sponsor | Psychiatrische Universitätsklinik Zürich |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Switzerland |
| Conditions | Investigate and compare the impact of Valproic acid and Pregabalin on healthy human volunteers 'anxiety-like' behaviour in a computer game. |
| Interventions | Group 1: Single dose 400 mg Valproic acid (2-Propylpentanoic acid), oral capsules for 1 day Group 2: Single dose 200 mg Pregabalin ((S)-3-(aminomethyl)-5-methylhexanoic acid), brand name Lyrica, oral capsules for 1 day Group 3: Single dose… |
| Registration date | Jan 4, 2016 |
| Target size | 90 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: